Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash Flows from Operating Activities
Net loss	$ (4,265,136)	$ (3,763,607)
Adjustments to reconcile net loss to net cash used in operating activities:
Noncash stock-based compensation expense	1,261,626	848,277
Amortization of ROU assets	83,965
Depreciation and amortization	50,499	18,021
PPP loan forgiveness		(81,550)
Amortization of future compensation payable	416,666	625,000
Amortization of prepaid assets	162,760	122,660
Loss on disposal of equipment	14,540
Changes in assets and liabilities:
Accounts receivable	(219,618)
Other assets		2,880
ROU liabilities	(53,959)	24,216
Prepaids and deposits	(237,097)	(48,218)
Accounts payable	53,863	(28,051)
Accrued interest		696
Accrued expenses and compensation	(11,063)	29
Net cash used in operating activities	(2,742,953)	(2,279,649)
Cash Flows from Investing Activities
Purchase of equipment	(78,996)	(206,198)
Net cash used in investing activities	(78,996)	(206,198)
Cash Flows from Financing Activities
Repayment on note payable	(460,002)	(1,102,113)
Proceeds from sale of common stock		5,299,000
Proceeds from note payable	175,435
Proceeds from subscription payable	585,000
Proceeds from exercise of stock options and warrants	14,250	108,000
Net cash provided by financing activities	314,682	4,304,887
Net change in cash and cash equivalents	(2,507,267)	1,819,042
Cash and cash equivalents, beginning of year	3,662,615	3,323,290
Cash and cash equivalents, end of period	1,155,349	5,142,332
Supplemental disclosure of cash flow information
Cash paid for interest	1,683	1,421
Cash paid for taxes
Non-cash investing and financing activities
Insurance financing for prepaid insurance	175,435	117,209
Implementation of ASC 842		617,569
Forgiveness of PPP loan		81,449
Equipment investing in accounts payable		64,107
Common stock issued for repayment of convertible notes		$ 47,499